Case Studies
Tilray Brands Reports Fiscal Q1 2027 Financial Results
NEW YORK - LONDON – Tilray Brands Inc. reported that ...
Virginia Lawmakers Send Cannabis Retail Framework to Governor’s Desk
RICHMOND – The Virginia General Assembly approved budget language that sets the terms for a regulated adult-use Сannabis market, sending the measure to Gov. Abigail Spanberger after a year of stalled bills and one rejected ...
Definium Clears Phase 3 Trial for its LSD-Based Depression Treatment
NEW YORK – Definium Therapeutics Inc. announced positive topline data from its Phase 3 Emerge study evaluating DT120, an orally disintegrating tablet (ODT) formulation of pharmaceutical LSD, in adults with major depressive disorder (MDD). The ...
Vireo Growth Finalizes Equity Stake in Two Maryland Dispensaries
MINNEAPOLIS – Vireo Growth Inc. announced that it has completed the acquisition of an indirect 49% equity interest in HA-MD, LLC, the entity that owns Chesapeake Integrated Health Institute and Maryland Alternative Relief, two licensed ...
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
Virginia Lawmakers Send Cannabis Retail Framework to Governor’s Desk
RICHMOND – The Virginia General Assembly approved budget language that sets the terms for a regulated adult-use Сannabis market, sending the measure to Gov. Abigail Spanberger after a year of stalled bills and one rejected ...
Definium Clears Phase 3 Trial for its LSD-Based Depression Treatment
NEW YORK – Definium Therapeutics Inc. announced positive topline data from its Phase 3 Emerge study evaluating DT120, an orally disintegrating tablet (ODT) formulation of pharmaceutical LSD, in adults with major depressive disorder (MDD). The ...
Vireo Growth Finalizes Equity Stake in Two Maryland Dispensaries
MINNEAPOLIS – Vireo Growth Inc. announced that it has completed the acquisition of an indirect 49% equity interest in HA-MD, LLC, the entity that owns Chesapeake Integrated Health Institute and Maryland Alternative Relief, two licensed ...
Montana’s Comprehensive Approach to Cannabis Regulation and Consumer Safety
LOS ANGELES- Montana's Cannabis Control Division (CCD) is spearheading efforts to ensure public health and safety through the implementation of the Montana Cannabis Regulation and Taxation Act. The legislation aims to provide safe access to ...
Virginia Governor’s Veto Stalls Cannabis Legalization Progress
LOS ANGELES- In a recent development in Virginia's cannabis legalization movement, Governor Glenn Youngkin vetoed legislation that would have established a legal marketplace for adult-use cannabis. This move has been seen as a setback for ...
Federal Seizures of Regulated Cannabis Products Impact New Mexico Businesses
NEW YORK- In recent weeks, U.S. Customs and Border Protection (CBP) agents have reportedly seized regulated cannabis products at least a dozen times at border checkpoints in New Mexico, impacting state-licensed cannabis businesses. This marks ...
Filament Health Reports Revenue Gains and Progress in Psychedelic Drug Development
LOS ANGELES- Filament Health Corp., a psychedelic drug developer, has reported its financial results for the fourth quarter and the full year ending December 31, 2023. The company showed notable revenue gains and a significant ...
California Proposes Supervised Psychedelic Therapy Bill
LOS ANGELES- In an innovative legislative move, California lawmakers have introduced a bipartisan bill that aims to permit individuals over the age of 21 to consume psychedelic mushrooms under professional supervision. This proposal seeks to ...
Health Canada Reclassifies Organigram’s Cannabis Lozenges as Edibles
NEW YORK- In a recent development that has stirred the Canadian cannabis industry, Health Canada has announced a pivotal decision affecting Organigram Holdings. The federal agency has reclassified the company's Edison Jolts lozenge products from ...
Chicago Atlantic Invests $20 Million in Nova Farms Expansion
LOS ANGELES- Chicago Atlantic, a significant player in financial investment, has finalized a $20 million senior secured financing deal with Nova Farms, an established cannabis operator. This strategic investment is aimed at bolstering Nova Farms' ...
Ohio Moves Forward with Adult-Use Cannabis Marketplace Regulations
LOS ANGELES- Ohio is on the verge of activating its adult-use cannabis marketplace following the state regulators' recent publication of the latest draft rules for the industry. This comprehensive framework, announced last week, introduces detailed ...
California Enhances Cannabis Equity with $12 Million Grant
NEW YORK- In a landmark move, California has allocated $12 million in grants to ten cities and counties, including Oakland and San Jose, as part of its commitment to fostering equity in the cannabis industry. ...
New Jersey Navigates Legal Waters on Off-Duty Cannabis Use by Police
LOS ANGELES- In a groundbreaking legal case in New Jersey, the debate over off-duty cannabis use by law enforcement officers brings to light the complex interplay between state legalization and federal restrictions. Jersey City has ...
New York Supreme Court Overturns Cannabis Marketing Restrictions
LOS ANGELES- In a significant legal development for New York's cannabis industry, the Supreme Court in Albany County invalidated several marketing restrictions on Monday, marking a pivotal moment for licensed cannabis businesses in the state. ...
New Mexico Sets Record in Cannabis Sales for March
LOS ANGELES- In a significant development within the cannabis industry, New Mexico reported a record-breaking total of over $52 million in combined recreational and medical cannabis sales for March. This figure surpasses previous records, marking ...
Petalfast Acquires Flow Distribution to Enhance National Cannabis Sales and Distribution Network
LOS ANGELES- Petalfast, a national sales and distribution platform in the cannabis industry, has finalized the acquisition of Flow Distribution's sales and distribution subsidiary, marking a significant expansion of its operations and brand portfolio in ...
ANALYSIS: Ukraine’s Medical Cannabis Legalization: A Journey of Hope and Resilience
KYIV--In the heart of Ukraine, amidst the bustling streets of its vibrant cities and the tranquil beauty of its countryside, a new era is dawning—one marked by the legalization of medical cannabis. Having immersed myself ...
Hawaii’s Adult-Use Cannabis Legalization Stalls
LOS ANGELES- In a recent development within Hawaii's legislative process, a pivotal House committee announced it will not advance a bill proposing the legalization and regulation of recreational cannabis, effectively halting the legislation for 2024. ...
Washington D.C. Enhances Medical Cannabis Regulations and Extends Tax Holiday
LOS ANGELES- In a significant legislative move, the Council of the District of Columbia has unanimously passed the "Medical Cannabis Patient Card Extension 4/20 Medical Cannabis Sales Tax Holiday Week Emergency Amendment Act of 2024." ...
DEA to Conduct Hearing on Psychedelic Substances Proposal
LOS ANGELES- The Drug Enforcement Administration (DEA) has announced plans to hold a hearing regarding the proposed classification of two psychedelic substances, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC), as Schedule I drugs under the Controlled Substances ...
Canadian Cannabis Sales Experience a Dip in January
NEW YORK- In January 2024, Canada witnessed a notable 11.5% drop in retail sales of legal adult-use cannabis compared to December 2023, as reported by Statistics Canada. Despite a revision that increased the total recreational ...
Alabama Seeks to Expand Medical Cannabis Licensing
LOS ANGELES- In an effort to resolve ongoing legal disputes surrounding its medical cannabis licensing process, Alabama has introduced a bill proposing an increase in the number of available licenses. Filed on Tuesday, the legislation ...
Oregon Reinstates Criminal Penalties for Drug Possession
LOS ANGELES- In a landmark reversal, Oregon Governor Tina Kotek has endorsed House Bill 4002, reintroducing criminal penalties for possession of controlled substances such as fentanyl, heroin, and methamphetamine. This action marks a departure from ...
Alberta Leads in Psychedelic-Assisted Therapy Coverage
NEW YORK- Alberta Blue Cross's recent endorsement of insurance coverage for Psychedelic-Assisted Therapy signifies a pioneering move in Canadian healthcare, positioning Alberta as the first province to officially support and regulate such treatments. This development ...
Georgia Implements New Age Restrictions and Regulations on Hemp-Derived Products
NEW YORK- In a recent legislative development, Georgia is poised to enforce a new law restricting the sale of hemp-derived cannabinoid products, including CBD and intoxicating substances like delta-8 THC and delta-9 THC, to individuals ...
Awakn Life Sciences Expands into U.S. with Oklahoma Licensing Agreement
LOS ANGELES- Awakn Life Sciences Corp., a biotechnology company specializing in the development of medication-assisted treatments for addiction, particularly focusing on Alcohol Use Disorder (AUD), announced a significant expansion of its operations into the United ...
Ontario Anticipates Record Cannabis Revenue
LOS ANGELES- In a landmark financial forecast, Ontario expects to garner over CA$379 million from its share of the federal cannabis duty for the fiscal year April 2024 to March 2025, marking a significant 22.2% ...
University of Calgary Studies Psychedelic Treatment for Alcohol Use Disorder
LOS ANGELES- The University of Calgary, through its Hotchkiss Brain Institute, has embarked on a study to examine the potential of psychedelics, specifically psilocybin, in treating Alcohol Use Disorder (AUD). With plans to recruit 128 ...
